Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
So the statement. . ."and the .02s will be here soon enough" is not a prediction? Okay then. LOL
Gman... my sentiments exactly.
Yes. . .Glenmark Pharmaceuticals USA is a division (subsidiary) of Glenmark Pharmaceuticals Ltd. The US division was established in 2003.
So once again I say nonsense to the below quoted info. And yes. . .it is my pleasure to clear up the misinformation.
Thanks, but my DD would again disagree. A branded generic can be filed under section 505(b)2.
Absolute nonsense.The fundamentals of Elite Pharma are looking better and better as each day passes.
Nonsense unless proof is posted
How many financial quarters did it take to file five ANDA's?
Nonsense. The FDA is encouraging the the development of ADT's with the eventual replacement of all non-abuse resistant products with ADT's.
Complete BS. Nasrat nor anybody else at Elite Pharma PROMISED one approval per quarter. Nasrat had stated they would attempt to submit one ANDA per quarter. There are now five submitted to the FDA with another ANDA anticipated to be submitted during this quarter.
More nonsense
Absolute bullshit. Nasrat is the only employee who has chosen to be paid all of his salary in shares. There are other employees who have ELECTED to be paid a portion of their salary in shares. Provide proof unhappy employees are leaving Elite.
It's another fundamental item to be added to the list by anybody conducting DD on ELTP. The value of this item is to be decided upon by each individual conducting their own research. To me, the 1.6 billion ANDA is another building block. . .another indicator the company is moving forward and executing its business plan.
Yep. . .as of July/2017 and going forward. What is sad, however. . . is that repeated requests in October for proof that Elite traded on the Frankfurt exchange went unanswered.
Please note the key operative words in my message, that being "will be competing". Nobody knows how much of a market share these ANDAS will garner when approved.
The list is inclusive of all companies traded FROM July/2017 going forward. Elite was not on that list in July, August, September or October/2017 or to this day.
Yes, wow. . .glad I could help.
Well. . .when these five ANDAS are approved they will be competing in a multi-billion dollar market. This quarter, another ANDA is expected to be submitted which, if approved, alone will compete in a 1.6 billion market.
I would think any savvy potential investors conducting DD would care to know this important fact. I believe the answer is 5 ANDAS currently submitted to the FDA.
LOL The list is saying Elite was NOT trading as of July/2017; so how can the claim be true that Elite was on the exchange in October when it was not present in July?
Well. . .if a search for Elite Pharma (ELTP) is conducted on the website below, it will show no references to ELTP. Please note the website provides access to: "The Complete List of Listed Companies on the Frankfurt Stock Exchange as of July, 2017". The conclusion can only be made that Elite does not trade on the Frankfurt exchange.
http://topforeignstocks.com/stock-lists/the-list-of-listed-companies-in-germany/
The allegation about Elite trading on the German exchange was made in October/2017. The list of companies traded on the exchange precedes that date (July 17/2017). So, it was not possible Elite was trading on the German exchange at the time the allegation was made. The allegation is of course is pure BS.
Yes, I remember the education included the declaration that Elite traded on the Frankfurt exchange.
Savvy investors would do their own DD. Savvy investors would seek out sources enabled with credible links such as SEC doc's. Savvy investors would place no credibility in unsubstantiated opinions.
Jimmy Joe, it is just a matter of time before an approval is announced. I am so looking forward to that day. Patience is definitely needed when possessing investments in the pharma sector. . .that is for sure.
Yes I agree, it is BS. The same allegation was made two years ago with no proof provided at that time.
Would have been nice to have a link showing the actual source of this info pertaining to the alleged ELTP contract.
Gman. . .you are 100% correct.
Thank you...and you as well.
Actually I have completed my own DD. Elite does not trade on the Frankfurt exchange or anywhere else overseas. So. . .it is not possible for ELTP to be down 18%.
ELTP trades overseas? This is news to me. Please post proof of exchange and ticker. I would be most interested in checking this out for myself.
Just more BS as usual. Yes this is basic stuff. The audited 10K would disgree.
https://www.irpass.com/profiles/investor/PdfView.aspx?b=2258&m=spdf&c=0001053369&ID=https%3A%2F%2Fwww%2Eirpass%2Ecom%2Fprofiles%2Finvestor%2FSecB2iView2%2Easp%3Fb%3D2258%26ID%3D35498%26c%3D0001053369%26m%3Dpdf
I am not concerned with the share price at this time. I do have an exit price in mind when the NDA/ANDA approvals become a reality and the share price appreciates considerably. I have a very nice stream of monthly income so I do not need to trade stocks for a living. In fact, if I were to sell at double or triple the present price then I will have made 200 - 300% on my investment that I have had since 2012. You cannot earn this kind of return with conventional investing instruments. I can afford to hang on for as long as it takes. Time is on my side. And for the record, I expect to garner a lot more from my investment than a double or triple of today's price.
So all that needs to be done is go the ELTP website and access SEC filings. Here, let me help. . .
https://www.irpass.com/profiles/investor/PdfView.aspx?b=2258&m=spdf&c=0001053369&ID=https%3A%2F%2Fwww%2Eirpass%2Ecom%2Fprofiles%2Finvestor%2FSecB2iView%2Easp%3Fb%3D2258%26ID%3D35497%26c%3D0001053369%26m%3Dpdf
Not even close. As of the last 10K (June 14/2017), insiders owned 268,000,000 shares (including J series = 156,000,000 shares). . .that is over 30% of the O/S.
Yes, the results from that pilot study were, in Nasrat's words, outstanding. We now await further guidance from the FDA as to what action(s) is required prior to the resubmittal of the SequestOx NDA. GLTU
So. . .in conclusion: The FDA has indicated a need for ADT opioid products and has issued guidelines to assist pharma's in the development of these commodities. This is exactly where Elite is . . .that they are now in the process of developing an ADT(s) product. LMAO